 HENDERSON, Nev, Jan. 8, 2023 PRNewswire VolitionRx Limited NYSE AMERICAN: VNRX Volition, a multi-national epigenetics company, has issued a Business Review of 2022, outlining its key highlights as the organization transitions from a company solely focused on research and development to one with commercial operations. Volitions major achievements in 2022 include: Expanding access to ...... 